Paper30596642
Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment.
Cokol M and 2 others. PLoS Comput Biol, 2018. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. Chemogenomic model identifies synergistic drug combinations robust to the pathogen microenvironment. Papers, record 30596642. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30596642
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics19
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Models, Biological | Major topic |
| Pharmacogenomic Testing | Major topic |
| Acinetobacter baumannii | |
| Computational Biology | |
| Drug Interactions | |
| Drug Resistance, Multiple, Bacterial | |
| Drug Synergism | |
| Drug Therapy, Combination | |
| Escherichia coli | |
| Genes, Bacterial | |
| Glycolysis | |
| Glyoxylates | |
| Host Microbial Interactions | |
| Humans | |
| Metabolic Networks and Pathways | |
| Microbial Sensitivity Tests | |
| Software | |
| Systems Biology |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P50 GM107618 | NIGMS NIH HHS | United States | P50GM107618 | PubMed and NIH |
Source NIH RePORTER
References47
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23251029 | Defining principles of combination drug mechanisms of action. | Proc Natl Acad Sci U S A | 2013 | https://conductscience.org/library/papers/23251029 | PubMed |
| 2 | 29026882 | Efficient measurement and factorization of high-order drug interactions in Mycobacterium tuberculosis. | Sci Adv | 2017 | https://conductscience.org/library/papers/29026882 | PubMed |
| 3 | 20211134 | Protein dynamics in drug combinations: a linear superposition of individual-drug responses. | Cell | 2010 | https://conductscience.org/library/papers/20211134 | PubMed |
| 4 | 17198971 | Multi-target therapeutics: when the whole is greater than the sum of the parts. | Drug Discov Today | 2007 | https://conductscience.org/library/papers/17198971 | PubMed |
| 5 | 27222539 | Chemogenomics and orthology-based design of antibiotic combination therapies. | Mol Syst Biol | 2016 | https://conductscience.org/library/papers/27222539 | PubMed |
| 6 | 26100898 | Antibiotic efficacy is linked to bacterial cellular respiration. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26100898 | PubMed |
| 7 | 26983881 | An Unbiased Oncology Compound Screen to Identify Novel Combination Strategies. | Mol Cancer Ther | 2016 | https://conductscience.org/library/papers/26983881 | PubMed |
| 8 | 16447111 | Bad bugs need drugs: an update on the development pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of America. | Clin Infect Dis | 2006 | https://conductscience.org/library/papers/16447111 | PubMed |
| 9 | 29049930 | Antibiotic efficacy-context matters. | Curr Opin Microbiol | 2017 | https://conductscience.org/library/papers/29049930 | PubMed |
| 10 | 21645016 | Metabolic regulation of antibiotic resistance. | FEMS Microbiol Rev | 2011 | https://conductscience.org/library/papers/21645016 | PubMed |
| 11 | 29249812 | Uncovering the mechanisms of Acinetobacter baumannii virulence. | Nat Rev Microbiol | 2018 | https://conductscience.org/library/papers/29249812 | PubMed |
| 12 | 17160061 | Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. | Nat Biotechnol | 2006 | https://conductscience.org/library/papers/17160061 | PubMed |
| 13 | 24978671 | Isocitrate lyase mediates broad antibiotic tolerance in Mycobacterium tuberculosis. | Nat Commun | 2014 | https://conductscience.org/library/papers/24978671 | PubMed |
| 14 | 15131650 | Chemogenomics: an emerging strategy for rapid target and drug discovery. | Nat Rev Genet | 2004 | https://conductscience.org/library/papers/15131650 | PubMed |
| 15 | 26284497 | Perturbation biology nominates upstream-downstream drug combinations in RAF inhibitor resistant melanoma cells. | Elife | 2015 | https://conductscience.org/library/papers/26284497 | PubMed |
| 16 | 18156341 | Fermentative utilization of glycerol by Escherichia coli and its implications for the production of fuels and chemicals. | Appl Environ Microbiol | 2008 | https://conductscience.org/library/papers/18156341 | PubMed |
| 17 | 1984787 | Effect of osmotic pressure on membrane energy-linked functions in Escherichia coli. | Biochim Biophys Acta | 1991 | https://conductscience.org/library/papers/1984787 | PubMed |
| 18 | 16216100 | Clinical impact and pathogenicity of Acinetobacter. | Clin Microbiol Infect | 2005 | https://conductscience.org/library/papers/16216100 | PubMed |
| 19 | 22773816 | Mechanism-independent method for predicting response to multidrug combinations in bacteria. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22773816 | PubMed |
| 20 | 24148302 | On the essentiality of lipopolysaccharide to Gram-negative bacteria. | Curr Opin Microbiol | 2013 | https://conductscience.org/library/papers/24148302 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42746190 | Human organoids and organ-on-chip systems for AI-guided therapeutic discovery against emerging and re-emerging infections. | Front Pharmacol | 2026 | https://conductscience.org/library/papers/42746190 | PubMed |
| 42413502 | TACTIC: A transfer learning framework to predict drug interactions in emerging pathogens. | Cell Rep Methods | 2026 | https://conductscience.org/library/papers/42413502 | PubMed |
| 42084367 | Transcriptome-constrained genome-scale metabolic modeling reveals central carbon and amino acid metabolic reprogramming underlying colistin-sulbactam synergy in Acinetobacter baumannii. | Antimicrob Agents Chemother | 2026 | https://conductscience.org/library/papers/42084367 | PubMed |
| 41940069 | A Metabolism-Informed Neural Network Identifies Pathways Influencing the Potency and Toxicity of Antimicrobial Combinations. | NPJ Drug Discov | 2026 | https://conductscience.org/library/papers/41940069 | PubMed |
| 41676326 | A comprehensive review of cluster methods for drug-drug interaction network. | Quant Biol | 2026 | https://conductscience.org/library/papers/41676326 | PubMed |
| 41181601 | GEODE: an in silico tool that translates in vitro to in vivo predictions of tuberculosis antibiotic combination efficacy. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/41181601 | PubMed |
| 41012523 | Machine Learning for Multi-Target Drug Discovery: Challenges and Opportunities in Systems Pharmacology. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/41012523 | PubMed |
| 40127266 | Large-scale combination screens reveal small-molecule sensitization of antibiotic-resistant gram-negative ESKAPE pathogens. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/40127266 | PubMed |
| 38895385 | Transfer learning predicts species-specific drug interactions in emerging pathogens. | bioRxiv | 2024 | https://conductscience.org/library/papers/38895385 | PubMed |
| 38515847 | In vivo screening for toxicity-modulating drug interactions identifies antagonism that protects against ototoxicity in zebrafish. | Front Pharmacol | 2024 | https://conductscience.org/library/papers/38515847 | PubMed |
| 37744101 | Systematic Prediction of Antifungal Drug Synergy by Chemogenomic Screening in Saccharomyces cerevisiae. | Front Fungal Biol | 2021 | https://conductscience.org/library/papers/37744101 | PubMed |
| 36016709 | A flux-based machine learning model to simulate the impact of pathogen metabolic heterogeneity on drug interactions. | PNAS Nexus | 2022 | https://conductscience.org/library/papers/36016709 | PubMed |
| 35849634 | Sample-efficient identification of high-dimensional antibiotic synergy with a normalized diagonal sampling design. | PLoS Comput Biol | 2022 | https://conductscience.org/library/papers/35849634 | PubMed |
| 35558105 | Discovery of Natural Products With Antifungal Potential Through Combinatorial Synergy. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35558105 | PubMed |
| 35370670 | ACDB: An Antibiotic Combination DataBase. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35370670 | PubMed |
| 35350764 | Prediction of Synergistic Antibiotic Combinations by Graph Learning. | Front Pharmacol | 2022 | https://conductscience.org/library/papers/35350764 | PubMed |
| 34469743 | Systematic measurement of combination-drug landscapes to predict in vivo treatment outcomes for tuberculosis. | Cell Syst | 2021 | https://conductscience.org/library/papers/34469743 | PubMed |
| 34431696 | Machine Learning of Bacterial Transcriptomes Reveals Responses Underlying Differential Antibiotic Susceptibility. | mSphere | 2021 | https://conductscience.org/library/papers/34431696 | PubMed |
| 34212403 | The future of antibiotics begins with discovering new combinations. | Ann N Y Acad Sci | 2021 | https://conductscience.org/library/papers/34212403 | PubMed |
| 32908144 | Antibiotic susceptibility signatures identify potential antimicrobial targets in the Acinetobacter baumannii cell envelope. | Nat Commun | 2020 | https://conductscience.org/library/papers/32908144 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/30596642
GET https://conductscience.org/api/papers/v1/30596642/references?page=2